Gilead Appoints Dietmar Berger as Chief Medical Officer

Posted on by admin

Berger joins Gilead with over 25 years of global drug development experience and will oversee the company’s virology, oncology, and inflammation portfolio.

Leave a Reply

Your email address will not be published. Required fields are marked *